WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011018710) BIOLOGICAL COMPONENTS WITHIN THE CEREBROSPINAL FLUID
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/018710    International Application No.:    PCT/IB2010/002201
Publication Date: 17.02.2011 International Filing Date: 13.08.2010
Chapter 2 Demand Filed:    10.06.2011    
IPC:
G01N 33/68 (2006.01)
Applicants: GENFIT [FR/FR]; 885 Avenue Eugène Avinée Parc Eurasanté F-59120 Loos (FR) (For All Designated States Except US).
DELERIVE, Philippe [FR/FR]; (FR) (For US Only).
MAJD, Zouher [FR/FR]; (FR) (For US Only)
Inventors: DELERIVE, Philippe; (FR).
MAJD, Zouher; (FR)
Agent: CABINET ORES; 36, rue de St Pétersbourg F-75008 Paris (FR)
Priority Data:
09290628.8 13.08.2009 EP
Title (EN) BIOLOGICAL COMPONENTS WITHIN THE CEREBROSPINAL FLUID
(FR) COMPOSANTS BIOLOGIQUES DANS LE LIQUIDE CÉPHALO-RACHIDIEN
Abstract: front page image
(EN)The invention provides novel methods for isolating, characterizing, comparing, and using biological components that are present in the cerebrospinal fluid. Such biological structures, called CS-MPs, can be used for identifying biomarkers that reflect the status (or anticipate the development) of disorders of the Central Nervous System (CNS).. The novel methods, biological products, and related kits make possible the use of CS-MPs and of their components as biomarkers for the diagnosis, prognosis, or monitoring of CNS disorders. The CS-MPs have a diameter comprised between 100 and 1000 nm and contain phosphatidylserine (PS).
(FR)L'invention concerne de nouveaux procédés pour l'isolement, la caractérisation, la comparaison et l'utilisation de composants biologiques qui sont présents dans le liquide céphalo-rachidien. De telles structures biologiques, nommées CS-MP, peuvent être utilisées pour identifier des biomarqueurs qui reflètent le statut (ou anticipent le développement) de troubles du système nerveux central (SNC). Les nouveaux procédés, produits biologiques et kits associés rendent possible l'utilisation de CS-MP et de leurs composants en tant que biomarqueurs pour le diagnostic, le pronostic ou le suivi de troubles du SNC.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)